• Pharmsville corrected its third-quarter 2026 report on November 13 to include omitted notes to its consolidated and separate financial statements.
• The correction was not prompted by a regulatory request or order.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmsville Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261113000360), on November 13, 2026, and is solely responsible for the information contained therein.